DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 88 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q2 2019. The put-call ratio across all filers is 7.52 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $16,721,776 | -12.3% | 1,314,605 | -3.0% | 0.01% | -14.3% |
Q2 2023 | $19,072,275 | +93345.7% | 1,354,565 | +2.5% | 0.01% | -12.5% |
Q1 2023 | $20,410 | +43.0% | 1,321,016 | +51.8% | 0.01% | +33.3% |
Q4 2022 | $14,268 | -99.9% | 870,500 | +7.0% | 0.01% | 0.0% |
Q3 2022 | $15,052,000 | +190.7% | 813,649 | +465.8% | 0.01% | +200.0% |
Q2 2022 | $5,177,000 | +13.5% | 143,798 | +13.4% | 0.00% | +100.0% |
Q1 2022 | $4,563,000 | +1.2% | 126,753 | +1.2% | 0.00% | 0.0% |
Q4 2021 | $4,508,000 | -5.5% | 125,217 | -13.5% | 0.00% | 0.0% |
Q3 2021 | $4,772,000 | +57.4% | 144,679 | -4.8% | 0.00% | 0.0% |
Q2 2021 | $3,032,000 | -5.9% | 151,957 | -5.9% | 0.00% | 0.0% |
Q1 2021 | $3,223,000 | -10.9% | 161,564 | -10.9% | 0.00% | 0.0% |
Q4 2020 | $3,619,000 | -0.2% | 181,390 | -0.2% | 0.00% | 0.0% |
Q3 2020 | $3,626,000 | -0.4% | 181,793 | -0.3% | 0.00% | 0.0% |
Q2 2020 | $3,639,000 | -16.1% | 182,420 | +73.2% | 0.00% | -50.0% |
Q1 2020 | $4,336,000 | -58.1% | 105,317 | -36.6% | 0.00% | -50.0% |
Q4 2019 | $10,342,000 | +0.8% | 166,157 | -45.0% | 0.00% | 0.0% |
Q3 2019 | $10,259,000 | +815.2% | 302,261 | +508.1% | 0.00% | – |
Q2 2019 | $1,121,000 | – | 49,708 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
New Leaf Venture Partners, L.L.C. | 4,104,140 | $93,041,000 | 43.52% |
SV Health Investors, LLC | 1,716,303 | $38,909,000 | 20.55% |
PURA VIDA INVESTMENTS, LLC | 68,154 | $1,545,000 | 0.65% |
Redmile Group, LLC | 683,880 | $14,658,000 | 0.64% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 77,000 | $1,746,000 | 0.62% |
SPHERA FUNDS MANAGEMENT LTD. | 224,154 | $5,008,000 | 0.59% |
EMERALD ADVISERS, LLC | 482,626 | $10,941,000 | 0.42% |
EMERALD MUTUAL FUND ADVISERS TRUST | 416,342 | $9,438,000 | 0.38% |
Orbimed Advisors | 1,176,070 | $26,662,000 | 0.34% |
VIKING GLOBAL INVESTORS LP | 2,394,625 | $54,286,000 | 0.33% |